Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results December 3, 2019 Relmada Therapeutics Announces Pricing of Public Offering of Common Stock October 17, 2019 Relmada to Ring NASDAQ Stock Market Opening Bell on Friday, October 18 October 15, 2019 Relmada Therapeutics Announces Top-Line Results from REL-1017 Phase 2 Study in Individuals with Treatment Resistant Depression October 14, 2019 Relmada Therapeutics to Announce Results of Phase 2 Study of REL-1017 for Treatment Resistant Depression and Conduct Conference Call on Tuesday, October 15 October 10, 2019 Relmada Therapeutics Announces Commencement of Trading on The NASDAQ Capital Market October 8, 2019 Relmada Therapeutics Announces Uplisting to The NASDAQ Capital Market September 27, 2019 Relmada Therapeutics Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market July 29, 2019 Relmada Therapeutics Announces Completion of Dosing with REL-1017 in Phase 2 Study of Individuals with Treatment Resistant Depression June 3, 2019 Relmada Therapeutics to Present at LD Micro Invitational Conference in Los Angeles May 31, 2019 Relmada Therapeutics Presents Development Program of REL1017 for Treatment of Depression at the 2019 American Society of Clinical Psychopharmacology Meeting «...131415161718...»
